Investors
ESW vision
is completing
its 10 years’
journey
Thanks to our financial investors, Ciclad and MCapital, two French equity funds, entering through an MBO in 2018, the global “kick-off” of our journey has been supported.
A new investment opportunity in Dry Eye innovation
Our Solutions for Advanced Dry Eye Screening and long-lasting efficient Dry Eye Treatment are registered (medical class II / III) in more than 60 countries worldwide. To set up next steps for our future product and market developments, a new opportunity for investors has been opened in June 2026.
Interested in our investment opportunities for our future journey?
Get in touch with our CEO, Petra Bruckmueller (pb@e-swin.com) or directly with our project advisors Rochefort Associates (op@rochefortassocies.com).
Get in touch with our team to learn more
